Your browser doesn't support javascript.
loading
Biomarkers and laboratory assessments for monitoring the treatment of patients with paroxysmal nocturnal hemoglobinuria: Differences between terminal and proximal complement inhibition.
Kulasekararaj, Austin G; Kuter, David J; Griffin, Morag; Weitz, Ilene C; Röth, Alexander.
Afiliación
  • Kulasekararaj AG; Department of Haematological Medicine, King's College Hospital, King's College London, and National Institute for Health and Care Research / Wellcome King's Clinical Research Facility, London, United Kingdom. Electronic address: austin.kulasekararaj@nhs.net.
  • Kuter DJ; Hematology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. Electronic address: dkuter@mgh.harvard.edu.
  • Griffin M; Department of Haematology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom. Electronic address: m.griffin@nhs.net.
  • Weitz IC; Jane Anne Nohl Division of Hematology, University of Southern California Keck School of Medicine, Los Angeles, CA, United States. Electronic address: iweitz@med.usc.edu.
  • Röth A; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Electronic address: alexander.roeth@uk-essen.de.
Blood Rev ; 59: 101041, 2023 05.
Article en En | MEDLINE | ID: mdl-36732204

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hemoglobinuria Paroxística Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Blood Rev Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hemoglobinuria Paroxística Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Blood Rev Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article